Rheumatology 2020;59:2563–2571
doi:10.1093/rheumatology/kez671
In the above article, image C and D in Figure 2 was originally a duplicate of image A and B. This has been corrected online and in print. The author apologises for the error.
. 2020 Oct 7;60(4):2033. doi: 10.1093/rheumatology/keaa612
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
Katie Bechman
1,✉, Anuoluwapo Oke
1,2, Mark Yates
1, Sam Norton
3, Elaine Dennison
2, Andrew P Cope
1, James B Galloway
1
Katie Bechman
1
Centre for Rheumatic Diseases, Kings College London, London, UK
Find articles by Katie Bechman
Anuoluwapo Oke
1
Centre for Rheumatic Diseases, Kings College London, London, UK
2
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK
Find articles by Anuoluwapo Oke
Mark Yates
1
Centre for Rheumatic Diseases, Kings College London, London, UK
Find articles by Mark Yates
Sam Norton
3
Psychology Department, Institute of Psychiatry, Kings College London, London, UK
Find articles by Sam Norton
Elaine Dennison
2
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK
Find articles by Elaine Dennison
Andrew P Cope
1
Centre for Rheumatic Diseases, Kings College London, London, UK
Find articles by Andrew P Cope
James B Galloway
1
Centre for Rheumatic Diseases, Kings College London, London, UK
Find articles by James B Galloway
1
Centre for Rheumatic Diseases, Kings College London, London, UK
2
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK
3
Psychology Department, Institute of Psychiatry, Kings College London, London, UK
✉
Correspondence to: Katie Bechman, Centre for Rheumatic Diseases, Weston Education Centre, King’s College London SE5 9RJ, UK. E-mail: katie.bechman@kcl.ac.uk
Collection date 2021 Apr.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC8023986 PMID: 33026092
This corrects the article "Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register" in volume 59 on page 2563.